WO2017193832A1 - Mitochondrial genomic library based on high-throughput sequencing and method for constructing the library - Google Patents

Mitochondrial genomic library based on high-throughput sequencing and method for constructing the library Download PDF

Info

Publication number
WO2017193832A1
WO2017193832A1 PCT/CN2017/082495 CN2017082495W WO2017193832A1 WO 2017193832 A1 WO2017193832 A1 WO 2017193832A1 CN 2017082495 W CN2017082495 W CN 2017082495W WO 2017193832 A1 WO2017193832 A1 WO 2017193832A1
Authority
WO
WIPO (PCT)
Prior art keywords
dna
mitochondrial
pcr
dna fragment
genomic library
Prior art date
Application number
PCT/CN2017/082495
Other languages
French (fr)
Chinese (zh)
Inventor
张巍
Original Assignee
广州嘉检医学检测有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 广州嘉检医学检测有限公司 filed Critical 广州嘉检医学检测有限公司
Publication of WO2017193832A1 publication Critical patent/WO2017193832A1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1093General methods of preparing gene libraries, not provided for in other subgroups
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00Libraries per se, e.g. arrays, mixtures
    • C40B40/04Libraries containing only organic compounds
    • C40B40/06Libraries containing nucleotides or polynucleotides, or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B50/00Methods of creating libraries, e.g. combinatorial synthesis
    • C40B50/06Biochemical methods, e.g. using enzymes or whole viable microorganisms

Definitions

  • the invention relates to the field of gene detection, in particular to a mitochondrial genome library based on high-throughput sequencing and a construction method thereof.
  • Mitochondria are organelles that produce energy in cells.
  • Mitochondrial DNA is a genetic material in mitochondria and is a double-stranded ring. There may be one or several mitochondrial DNA molecules in one mitochondria.
  • Human mitochondrial DNA (mtDNA) contains 37 genes, of which 22 genes encode transfer ribonucleic acid (tRNA), 2 genes encode ribosomal ribonucleic acid (12S and 16SrRNA), and 13 genes encode polypeptides. These mitochondrial genome genes are essential for mitochondria to produce functional proteins, and mitochondrial ribosomes are ribosomes present in the mitochondrial matrix responsible for translational work in the mitochondria.
  • Mitochondrial diseases are diseases caused by abnormal function of mitochondria. Mitochondrial diseases are often caused by mutations in mitochondrial DNA. These gene mutations may be on mtDNA or on nuclear genes. For mitochondrial genome analysis in patients with mitochondrial disease, it is found that the related gene mutation is an ideal genetic diagnosis method. Due to the large number of genes involved in mitochondrial diseases, only a few common mitochondrial gene loci can be selected for mutation and deletion screening in the clinic. The positive rate is very low, and most patients have difficulty obtaining accurate cause diagnosis.
  • High-throughput sequencing technology also known as second-generation sequencing, next-generation sequencing, deep sequencing, or massively parallel sequencing, is a revolutionary change to traditional sequencing, sequencing hundreds of thousands to millions of DNA molecules at a time. .
  • the core idea is Sequencing by Synthesis, which determines the sequence of DNA by capturing the newly synthesized ends of the markers.
  • High-throughput sequencing makes it possible to perform detailed analysis of the transcriptome and genome of a species.
  • High-throughput sequencing technology is extremely important in research and clinical applications due to its ultra-high sequencing capabilities.
  • second-generation sequencing greatly reduces the cost of DNA analysis
  • the sample preparation process is still cumbersome and has become an obstacle to its widespread application in the future. Therefore, a lot of research has been done on its DNA library construction method in order to simplify the preparation steps of the sample.
  • the Chinese Patent Application Publication No. CN 104894651 A discloses a high-throughput sequencing library construction method for microinitial DNA and a high-throughput sequencing library constructed thereby.
  • the method comprises the following steps: step S1, physically interrupting the sample DNA to obtain fragmented DNA; step S2, performing end repair on the fragmented DNA and adding A to obtain repair DNA; and step S3, using the connection enhancer to repair the DNA.
  • the linker is ligated to obtain a linker fragment; in step S4, the linker fragment is amplified to obtain a high-throughput sequencing library;
  • the linker enhancer is DMSO, ethanol, ethylene glycol or glycerol.
  • the constructing method further comprises the step of magnetic bead purification of the tapped fragment.
  • the ligation fragment is subjected to stepwise amplification and the step of magnetic bead purification is added after each amplification.
  • the step S4 includes: amplifying the band-joined fragment by 4 to 7 cycles to obtain a first amplified fragment; and performing 0.95 to 1.20 times of volume of the first amplified fragment to purify the magnetic bead to obtain a first expansion.
  • Amplifying the purified fragment amplifying the first amplified purified fragment for 6 to 9 cycles to obtain a second amplified fragment; and purifying the second amplified fragment by 0.95 to 1.20 times the volume of the magnetic bead to obtain a second Amplifying the purified fragment; and sorting the second amplified purified fragment with 0.7 to 0.85 volumes of magnetic beads to obtain the high-throughput sequencing library.
  • the purification of the magnetic beads is carried out separately and the amount of the magnetic beads is different, and the purification operation is complicated.
  • the present invention provides a mitochondrial genomic library based on high-throughput sequencing and a method for constructing the same.
  • a method for constructing a mitochondrial genomic library based on high-throughput sequencing comprising the following steps:
  • the step S1 is specifically: extracting whole blood DNA, and using the template as a template to PCR-amplify the mitochondrial full-length DNA.
  • the specific sequence of the primer pair used in step S1 is Primer F: ccgcacaagagtgctactctcctc, Primer R: gatattgatttcacggaggatggtg.
  • the PCR reaction system in the step S1 is as follows:
  • the procedure of the PCR reaction in the step S1 is as follows:
  • the reaction system of the pre-LM-PCR is as follows:
  • the reaction conditions of the pre-LM-PCR are as follows: 98 ° C 45 sec; 98 ° C 15 sec, 60 ° C 30 sec, 72 ° C 30 sec, 9 cycles; 72 ° C 1 min; 4 ° C.
  • the system of the post PCR reaction is as follows:
  • the conditions of the post-PCR reaction are as follows: 98 ° C 45 sec; 98 ° C 15 sec, 60 ° C 30 sec, 72 ° C 30 sec, 14 cycles; 72 ° C 1 min; 4 ° C.
  • said steps S3-S7 comprise a purification step.
  • the purification step is: adding the corresponding reaction solution to the sample and mixing, incubating at room temperature for 10 minutes, and fully combining the DNA with the magnetic beads; placing the tube on the magnetic stand until the solution becomes clear, discarding the supernatant, and The tube is kept on the magnetic stand, add 80% alcohol, incubate at room temperature for more than 30 seconds, absorb the alcohol, keep the tube on the magnetic stand, add 80% alcohol, incubate for 30 seconds at room temperature, absorb alcohol; dry.
  • the tube is taken out from the magnetic stand, and 10 mM Tris-HCl, pH 8.0, is added, and the mixture is incubated at room temperature for 2 minutes.
  • a mitochondrial genomic library based on high-throughput sequencing was constructed by the above-described mitochondrial genomic library construction method.
  • the present invention has the following beneficial effects:
  • the mitochondrial genomic library construction method of the present invention can obtain the mitochondrial full-length DNA by one-step PCR amplification from total DNA, which can ensure the accurate amplification of the human mitochondrial genome, and is not contaminated by homologous sequences in the human genome to make the mutation detection more sensitive and accurate. And save time; different sequences can be introduced for high-throughput sequencing by performing pre-LM-PCR; a sufficient amount of DNA can be obtained by performing post-PCR for subsequent high-throughput sequencing.
  • the mitochondrial genomic library construction method of the invention is purified by terminal repair, addition of A, addition of linker, pre-LM-PCR and post-PCR, and the DNA is not separated from the magnetic beads after end repair and addition of A, which simplifies the operation steps and saves the operation. time.
  • the high-throughput sequencing of the mitochondrial DNA library constructed by the present invention is carried out for bioinformatic analysis to obtain the mitochondrial genomic DNA sequence of the test sample, and different mutation types can be detected and quantified. Because high-throughput sequencing has high sensitivity to common and rare variants, most of the disease-related variants in the exon region of the coding region of mitochondria can be found.
  • the sensitivity of mutation detection can be increased by increasing the depth of sequencing. At 5000x coverage depth, more sequence information is obtained for statistical analysis, and the sensitivity can be achieved from 0.1 to 1%.
  • Figure 1 is an electropherogram of the PCR product in step S1.
  • Figure 2 is a fragmentation electrophoresis pattern in step S2.
  • Figure 3 is an electrophoresis pattern of the purified LM-PCR product in step S6.
  • Figure 4 is an electrophoresis pattern of the purified PCR product in step S7.
  • reaction mixture (A-Tailing Master Mix, 50 ⁇ l):
  • a method for mitochondrial genome detection and analysis based on high-throughput sequencing comprising the following steps:
  • DNA was extracted from 300 ⁇ l of whole blood according to a conventional method, and 2 ⁇ l of the DNA sample was subjected to concentration determination on a NanoDrop.
  • the measured DNA concentration requires an OD260/OD280 ratio between 1.8 and 2.0, and an OD260/OD230 ratio between 1.8 and 2.2.
  • the above two ratios can determine the purity of the extracted DNA. If it is outside the above range, it can be considered that the purity of the extracted DNA does not meet the requirements and needs to be re-extracted or re-purified. Further diluted to a concentration of 50 ng/ ⁇ l with DNA lysis buffer according to the measured concentration.
  • the mitochondrial full-length DNA was amplified by one-step PCR using the diluted whole blood DNA as a template.
  • the PCR reaction system is shown in Table 1.
  • the primer pair used in this example was designed by the inventors according to the disclosed mitochondrial sequence, and the mitochondrial full-length DNA can be amplified, and the specific sequence is as follows:
  • Primer F (SEQ ID NO: 1): ccgcacaagagtgctactctcctc,
  • Primer R (SEQ ID NO: 2): gatattgatttcacggaggatggtg.
  • Lane 1 is a molecular size marker
  • lanes 2 and 3 are mitochondrial amplification of different samples, approximately 16 kb in size
  • lane 4 is a negative control.
  • the amplified genomic DNA was disrupted with a Q800R sonicator. Specific steps are as follows:
  • the first lane is a molecular size marker, and the second and third lanes are DNA interrupts for different samples.
  • the fragment size is below 500 bp and the peak is about 350 bp.
  • the specific method of purification was as follows: 120 ⁇ l of Agencourt R AMPure R XP reagent was added to each sample in a total volume of 190 ⁇ l. Use a pipette to repeatedly pipe up and down and mix well. Incubate for 10 minutes at room temperature to allow the DNA to bind well to the magnetic beads. Place the tube on the magnetic stand until the solution becomes clear and carefully discard the supernatant. Leave the tube on the magnetic stand and add 200 ⁇ l of 80% alcohol. Incubate for 30 seconds at room temperature and carefully remove the alcohol. Leave the tube on the magnetic stand and add 200 ⁇ l of 80% alcohol. Incubate at room temperature for more than 30 seconds, carefully remove the alcohol. This step should be as clean as possible, but care should be taken not to remove the magnetic beads from the bottom. Dry at room temperature. Take the tube out of the magnetic stand.
  • the specific method of purification was as follows: 90 ⁇ l of PEG/NaclSPRI R Solution was added to each sample in a total volume of 140 ⁇ l. Use a pipette to repeatedly pipe up and down and mix well. Incubate for 10 minutes at room temperature to allow the DNA to bind well to the magnetic beads. Place the tube on the magnetic stand until the solution becomes clear and carefully discard the supernatant. Leave the tube on the magnetic stand and add 200 ⁇ l of 80% alcohol. Incubate for 30 seconds at room temperature and carefully remove the alcohol. Leave the tube on the magnetic stand and add 200 ⁇ l of 80% alcohol. Incubate at room temperature for more than 30 seconds, carefully remove the alcohol. This step should be as clean as possible, but care should be taken not to remove the magnetic beads from the bottom. Dry at room temperature.
  • thermocycler amplifier
  • the amplified DNA concentration and fragment size were determined by 1.5% gel electrophoresis, Nanodrop and Qubit. As shown in Fig. 3, the first lane is a molecular size marker, and the second and third lanes are for pre-LM-PCR of different samples, and the fragment size is about 400 bp.
  • the DNA concentrations of the two samples in lanes 2 and 3 after amplification by Qubit assay were 34.2 ng/ ⁇ l and 42.2 ng/ ⁇ l, respectively.
  • the magnetic beads were dissolved with 52 ⁇ l of NF water.
  • the pipette was blown 10 times at room temperature for 2 min. Place the tube back into the magnetic plate until the solution becomes clear.
  • Each sample was directly transferred from 50 ⁇ l to a 1.5 ml centrifuge tube.
  • the amplified DNA concentration and fragment size were determined by 1.5% gel electrophoresis, Qubit and qPCR. After multiplex PCR, a 68 bp addenda will be added to the product at this time. Care should be taken to see if the peaks appear consistent.
  • the gel electrophoresis pattern is shown in Fig. 4. The first lane is a molecular size marker, and the second and third lanes are post-PCR for different samples, and the peak value is about 400 bp.
  • the following table shows the DNA concentrations after amplification by Qubit and qPCR assays as shown in Table 6.
  • the high-throughput sequencing of the mitochondrial DNA library constructed by the present invention is carried out for bioinformatic analysis to obtain the mitochondrial genomic DNA sequence of the test sample, and different mutation types can be detected and quantified. Because high-throughput sequencing has high sensitivity to common and rare variants, most of the disease-related variants in the exon region of the coding region of mitochondria can be found.
  • the sensitivity of mutation detection can be increased by increasing the depth of sequencing. At 5000x coverage depth, more sequence information is obtained for statistical analysis, and the sensitivity can be achieved from 0.1 to 1%.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Bioinformatics & Computational Biology (AREA)

Abstract

A mitochondrial genomic library based on high-throughput sequencing and a method for constructing the library. The method comprises the following steps: S1. performing a one-step PCR amplification of total mitochondrial DNA from total DNA; S2. fragmenting the total mitochondrial DNA to obtain a DNA fragment; S3. performing end repair on the DNA fragment to obtain a blunt-end DNA fragment; S4. A-tailing a 3' end of the blunt-end DNA fragment to obtain an A-tailed DNA fragment; S5. adding a linker on the 3' end of the A-tailed DNA fragment to obtain a DNA fragment with linkers; S6. performing LM-PCR on the DNA fragment with linkers; and S7. performing PCR on an LM-PCR product. The method for constructing the mitochondrial genomic library performs PCR amplification on total DNA to obtain total mitochondrial DNA, thereby ensuring accurate amplification of a human mitochondrial genome and improving the accuracy and precision of mutation detection by preventing contamination or mixing of a homologous sequence from a human genome.

Description

一种基于高通量测序的线粒体基因组文库及其构建方法Mitochondrial genomic library based on high-throughput sequencing and construction method thereof 技术领域Technical field
本发明涉及基因检测领域,尤其涉及一种基于高通量测序的线粒体基因组文库及其构建方法。The invention relates to the field of gene detection, in particular to a mitochondrial genome library based on high-throughput sequencing and a construction method thereof.
背景技术Background technique
线粒体是细胞内产生能量的细胞器。线粒体DNA是线粒体中的遗传物质,呈双链环状。一个线粒体中可有一个或数个线粒体DNA分子。人类线粒体DNA(mtDNA),共包含37个基因,其中,22个基因编码转移核糖核酸(tRNA),2个基因编码核糖体核糖核酸(12S和16SrRNA),13个基因编码多肽。这些线粒体基因组上的基因是线粒体产生功能蛋白所必不可少,而且线粒体核糖体是存在于线粒体基质内的一种核糖体,负责完成线粒体内进行的翻译工作。Mitochondria are organelles that produce energy in cells. Mitochondrial DNA is a genetic material in mitochondria and is a double-stranded ring. There may be one or several mitochondrial DNA molecules in one mitochondria. Human mitochondrial DNA (mtDNA) contains 37 genes, of which 22 genes encode transfer ribonucleic acid (tRNA), 2 genes encode ribosomal ribonucleic acid (12S and 16SrRNA), and 13 genes encode polypeptides. These mitochondrial genome genes are essential for mitochondria to produce functional proteins, and mitochondrial ribosomes are ribosomes present in the mitochondrial matrix responsible for translational work in the mitochondria.
线粒体疾病是由于线粒体的功能不正常而导致的一些疾病。线粒体疾病往往是由于线粒体DNA的突变造成的。这些基因突变可能在mtDNA上,也可能发生在核基因上。对于线粒体疾病患者进行线粒体基因组的分析而发现相关基因突变是一种理想的遗传学诊断方法。由于线粒体病涉及基因众多,目前临床只能选择少数常见的线粒体基因位点进行突变和缺失筛查,阳性率很低,大多数患者难以获得准确的病因诊断。Mitochondrial diseases are diseases caused by abnormal function of mitochondria. Mitochondrial diseases are often caused by mutations in mitochondrial DNA. These gene mutations may be on mtDNA or on nuclear genes. For mitochondrial genome analysis in patients with mitochondrial disease, it is found that the related gene mutation is an ideal genetic diagnosis method. Due to the large number of genes involved in mitochondrial diseases, only a few common mitochondrial gene loci can be selected for mutation and deletion screening in the clinic. The positive rate is very low, and most patients have difficulty obtaining accurate cause diagnosis.
高通量测序技术也称二代测序、下一代测序技术、深度测序或大规模平行测序,它是对传统测序一次革命性的改变,一次对几十万到几百万条DNA分子进行序列测定。其核心思想是边合成边测序(Sequencing by Synthesis),即通过捕捉新合成的末端的标记来确定DNA的序列。高通量测序使得对一个物种的转录组和基因组进行细致全貌的分析成为可能。目前,主要有三种主流的测序平台:illumina公司Hiseq平台、life technologies公司的PGM平 台以及Roche公司的454平台。High-throughput sequencing technology, also known as second-generation sequencing, next-generation sequencing, deep sequencing, or massively parallel sequencing, is a revolutionary change to traditional sequencing, sequencing hundreds of thousands to millions of DNA molecules at a time. . The core idea is Sequencing by Synthesis, which determines the sequence of DNA by capturing the newly synthesized ends of the markers. High-throughput sequencing makes it possible to perform detailed analysis of the transcriptome and genome of a species. At present, there are three main types of sequencing platforms: illumina company Hiseq platform, life technologies company PGM level Taiwan and Roche's 454 platform.
高通量测序技术由于其超高的测序能力在科研和临床中具有极为重要的应用。然而,虽然二代测序大大降低了DNA分析的成本,其样本制备过程依然繁琐,成为其今后广泛应用中的一种障碍。因此,人们对其DNA文库构建方法进行了大量研究,以期简化样本的制备步骤。High-throughput sequencing technology is extremely important in research and clinical applications due to its ultra-high sequencing capabilities. However, although second-generation sequencing greatly reduces the cost of DNA analysis, the sample preparation process is still cumbersome and has become an obstacle to its widespread application in the future. Therefore, a lot of research has been done on its DNA library construction method in order to simplify the preparation steps of the sample.
如公开号为CN 104894651 A的中国发明专利申请公开了一种微量起始DNA的高通量测序文库构建方法及其所构建的高通量测序文库。该构建方法包括:步骤S1、对样本DNA进行物理打断,得到片段化DNA;步骤S2、对片段化DNA进行末端修复及加A,得到修复DNA;步骤S3、利用连接增强剂对修复DNA进行接头连接,得到带接头片段;步骤S4、对带接头片段进行扩增,得到高通量测序文库;连接增强剂为DMSO、乙醇、乙二醇或甘油。在所述步骤S3之后以及所述步骤S4之前,所述构建方法还包括对所述带接头片段进行磁珠纯化的步骤。对所述连接片段进行分步扩增,并在每次扩增之后增加磁珠纯化的步骤。所述步骤S4包括:对所述带接头片段扩增4~7个循环,得到第一扩增片段;对所述第一扩增片段进行0.95~1.20倍体积的磁珠纯化,得到第一扩增纯化片段;对所述第一扩增纯化片段扩增6~9个循环,得到第二扩增片段;对所述第二扩增片段进行0.95~1.20倍体积的磁珠纯化,得到第二扩增纯化片段;以及利用0.7~0.85倍体积的磁珠对所述第二扩增纯化片段进行分选,得到所述高通量测序文库。该发明中磁珠纯化分开进行且磁珠用量不同,纯化操作复杂。The Chinese Patent Application Publication No. CN 104894651 A discloses a high-throughput sequencing library construction method for microinitial DNA and a high-throughput sequencing library constructed thereby. The method comprises the following steps: step S1, physically interrupting the sample DNA to obtain fragmented DNA; step S2, performing end repair on the fragmented DNA and adding A to obtain repair DNA; and step S3, using the connection enhancer to repair the DNA. The linker is ligated to obtain a linker fragment; in step S4, the linker fragment is amplified to obtain a high-throughput sequencing library; the linker enhancer is DMSO, ethanol, ethylene glycol or glycerol. After the step S3 and before the step S4, the constructing method further comprises the step of magnetic bead purification of the tapped fragment. The ligation fragment is subjected to stepwise amplification and the step of magnetic bead purification is added after each amplification. The step S4 includes: amplifying the band-joined fragment by 4 to 7 cycles to obtain a first amplified fragment; and performing 0.95 to 1.20 times of volume of the first amplified fragment to purify the magnetic bead to obtain a first expansion. Amplifying the purified fragment; amplifying the first amplified purified fragment for 6 to 9 cycles to obtain a second amplified fragment; and purifying the second amplified fragment by 0.95 to 1.20 times the volume of the magnetic bead to obtain a second Amplifying the purified fragment; and sorting the second amplified purified fragment with 0.7 to 0.85 volumes of magnetic beads to obtain the high-throughput sequencing library. In the invention, the purification of the magnetic beads is carried out separately and the amount of the magnetic beads is different, and the purification operation is complicated.
发明内容Summary of the invention
有鉴于此,有必要针对上述的问题,本发明提供一种基于高通量测序的线粒体基因组文库及其构建方法。In view of the above, it is necessary to address the above problems, and the present invention provides a mitochondrial genomic library based on high-throughput sequencing and a method for constructing the same.
为了实现上述目的,本发明采用如下技术方案: In order to achieve the above object, the present invention adopts the following technical solutions:
一种基于高通量测序的线粒体基因组文库构建方法,包括以下步骤:A method for constructing a mitochondrial genomic library based on high-throughput sequencing, comprising the following steps:
S1、自总DNA中用一步PCR扩增线粒体全长DNA;S1, amplification of mitochondrial full-length DNA by one-step PCR from total DNA;
S2、将线粒体全长DNA打碎,得到DNA片段;S2, breaking the mitochondrial full-length DNA to obtain a DNA fragment;
S3、对DNA片段进行末端修复,得到平末端DNA片段;S3, performing end repair on the DNA fragment to obtain a blunt-ended DNA fragment;
S4、在平末端DNA片段3’端加A,得到加A的DNA片段;S4, adding A to the 3' end of the blunt-ended DNA fragment to obtain a DNA fragment with A added;
S5、在加A的DNA片段的3’端加接头,得到加接头的DNA片段;S5, adding a linker at the 3' end of the DNA fragment added with A to obtain a DNA fragment to which a linker is added;
S6、对加接头的DNA片段进行前LM-PCR;S6, performing pre-LM-PCR on the DNA fragment of the adaptor;
S7、对LM-PCR产物进行后PCR。S7, post-PCR is performed on the LM-PCR product.
优选地,所述步骤S1具体为:提取全血DNA,并以其为模板PCR扩增线粒体全长DNA。Preferably, the step S1 is specifically: extracting whole blood DNA, and using the template as a template to PCR-amplify the mitochondrial full-length DNA.
更优选地,步骤S1中所用引物对的具体序列为Primer F:ccgcacaagagtgctactctcctc,Primer R:gatattgatttcacggaggatggtg。More preferably, the specific sequence of the primer pair used in step S1 is Primer F: ccgcacaagagtgctactctcctc, Primer R: gatattgatttcacggaggatggtg.
优选地,所述步骤S1中PCR反应体系如下:Preferably, the PCR reaction system in the step S1 is as follows:
Figure PCTCN2017082495-appb-000001
Figure PCTCN2017082495-appb-000001
优选地,所述步骤S1中PCR反应的程序如下:Preferably, the procedure of the PCR reaction in the step S1 is as follows:
Lid:105℃,Wait,Auto;Block:95℃,2min;Lid: 105 ° C, Wait, Auto; Block: 95 ° C, 2 min;
95℃,20sec;68℃,18min;30cycles;95 ° C, 20 sec; 68 ° C, 18 min; 30 cycles;
72℃,20min;4℃,hold。 72 ° C, 20 min; 4 ° C, hold.
优选地,前LM-PCR的反应体系如下:Preferably, the reaction system of the pre-LM-PCR is as follows:
Figure PCTCN2017082495-appb-000002
Figure PCTCN2017082495-appb-000002
优选地,前LM-PCR的反应条件如下:98℃45sec;98℃15sec,60℃30sec,72℃30sec,9cycles;72℃1min;4℃。Preferably, the reaction conditions of the pre-LM-PCR are as follows: 98 ° C 45 sec; 98 ° C 15 sec, 60 ° C 30 sec, 72 ° C 30 sec, 9 cycles; 72 ° C 1 min; 4 ° C.
优选地,后PCR反应的体系如下:Preferably, the system of the post PCR reaction is as follows:
Figure PCTCN2017082495-appb-000003
Figure PCTCN2017082495-appb-000003
优选地,后PCR反应的条件如下:98℃45sec;98℃15sec,60℃30sec,72℃30sec,14cycles;72℃1min;4℃。Preferably, the conditions of the post-PCR reaction are as follows: 98 ° C 45 sec; 98 ° C 15 sec, 60 ° C 30 sec, 72 ° C 30 sec, 14 cycles; 72 ° C 1 min; 4 ° C.
优选地,所述步骤S3-S7包含纯化步骤。Preferably, said steps S3-S7 comprise a purification step.
优选地,纯化步骤为:向样本中加入相应的反应液混匀,室温孵育10分钟,使DNA与磁珠充分结合;将管放置于磁力架上,直至溶液变清澈,弃掉上清,将管继续留在磁力架上,加入80%酒精,室温孵育30秒以上,吸走酒精,将管继续留在磁力架上,加入80%酒精,室温孵育30秒以上,吸走酒精;室温下充分干燥。Preferably, the purification step is: adding the corresponding reaction solution to the sample and mixing, incubating at room temperature for 10 minutes, and fully combining the DNA with the magnetic beads; placing the tube on the magnetic stand until the solution becomes clear, discarding the supernatant, and The tube is kept on the magnetic stand, add 80% alcohol, incubate at room temperature for more than 30 seconds, absorb the alcohol, keep the tube on the magnetic stand, add 80% alcohol, incubate for 30 seconds at room temperature, absorb alcohol; dry.
更优选地,当需要将DNA与磁珠分离时,纯化后将管从磁力架上取出,加入pH 8.0的10mM Tris-HCl,室温孵育2分钟即可。More preferably, when it is necessary to separate the DNA from the magnetic beads, after purification, the tube is taken out from the magnetic stand, and 10 mM Tris-HCl, pH 8.0, is added, and the mixture is incubated at room temperature for 2 minutes.
一种基于高通量测序的线粒体基因组文库,通过上述线粒体基因组文库构建方法构建。 A mitochondrial genomic library based on high-throughput sequencing was constructed by the above-described mitochondrial genomic library construction method.
与现有技术相比,本发明具有如下有益效果:Compared with the prior art, the present invention has the following beneficial effects:
本发明线粒体基因组文库构建方法通过自总DNA中一步PCR扩增得到线粒体全长DNA,可以保障人类线粒体基因组的精确扩增,不被在人类基因组的同源序列污染混合使突变检测更灵敏和准确,且节省了时间;通过进行前LM-PCR可以引入不同序列以备高通量测序使用;通过进行后PCR可以获得足够数量的DNA,以便进行后续高通量测序。The mitochondrial genomic library construction method of the present invention can obtain the mitochondrial full-length DNA by one-step PCR amplification from total DNA, which can ensure the accurate amplification of the human mitochondrial genome, and is not contaminated by homologous sequences in the human genome to make the mutation detection more sensitive and accurate. And save time; different sequences can be introduced for high-throughput sequencing by performing pre-LM-PCR; a sufficient amount of DNA can be obtained by performing post-PCR for subsequent high-throughput sequencing.
本发明线粒体基因组文库构建方法在末端修复、加A、加接头、前LM-PCR和后PCR后进行纯化,且末端修复、加A后纯化DNA不与磁珠分离,简化了操作步骤,节省了时间。The mitochondrial genomic library construction method of the invention is purified by terminal repair, addition of A, addition of linker, pre-LM-PCR and post-PCR, and the DNA is not separated from the magnetic beads after end repair and addition of A, which simplifies the operation steps and saves the operation. time.
对本发明构建的线粒体DNA文库进行高通量测序,进行生物信息分析得到检测样本线粒体基因组DNA序列,便可检测出不同突变类型和对之进行定量。由于高通量测序具有对常见和罕见变异高灵敏度,能发现线粒体的编码区外显子区绝大部分疾病相关变异。可以通过增加测序深度,提高突变检测的敏感度。在5000x的覆盖深度,获得更多的序列信息进行统计分析,可以达到的敏感度为0.1-1%。The high-throughput sequencing of the mitochondrial DNA library constructed by the present invention is carried out for bioinformatic analysis to obtain the mitochondrial genomic DNA sequence of the test sample, and different mutation types can be detected and quantified. Because high-throughput sequencing has high sensitivity to common and rare variants, most of the disease-related variants in the exon region of the coding region of mitochondria can be found. The sensitivity of mutation detection can be increased by increasing the depth of sequencing. At 5000x coverage depth, more sequence information is obtained for statistical analysis, and the sensitivity can be achieved from 0.1 to 1%.
附图说明DRAWINGS
图1为步骤S1中PCR产物电泳图。Figure 1 is an electropherogram of the PCR product in step S1.
图2为步骤S2中片段打碎电泳图。Figure 2 is a fragmentation electrophoresis pattern in step S2.
图3为步骤S6中前LM-PCR产物纯化后电泳图。Figure 3 is an electrophoresis pattern of the purified LM-PCR product in step S6.
图4为步骤S7中后PCR产物纯化后电泳图。Figure 4 is an electrophoresis pattern of the purified PCR product in step S7.
具体实施方式detailed description
为了更好的说明本发明,下面结合附图和具体实施方式做进一步说明。除有特殊说明外,本发明中所用的试剂、设备或方法等都是本领域技术人员 所熟知的,在此不再赘述。The invention will be further described with reference to the drawings and specific embodiments. Unless otherwise specified, the reagents, equipment or methods used in the present invention are those skilled in the art. Well-known, no longer repeat here.
本发明中使用的以下试剂的配方如下:The formulations of the following reagents used in the present invention are as follows:
末端修复反应混合物(End Repair Master Mix,20μl):End Repair Master Mix (20 μl):
水                                8μlWater 8μl
10×KAPA End Repair Buffer        7μl10×KAPA End Repair Buffer 7μl
KAPA End Repair Enzyme Mix        5μl。KAPA End Repair Enzyme Mix 5μl.
加A反应混合物(A-Tailing Master Mix,50μl):Add A reaction mixture (A-Tailing Master Mix, 50 μl):
水                                42μlWater 42μl
10×KAPA A-Tailing Buffer         5μl10×KAPA A-Tailing Buffer 5μl
KAPA A-Tailing Enzyme             3μl。KAPA A-Tailing Enzyme 3μl.
连接混合物(Ligation Master Mix,55μl):Ligation Master Mix (55 μl):
水                                30μlWater 30μl
5×KAPA Ligation Buffer           10μl5×KAPA Ligation Buffer 10μl
KAPA T4 DNA Ligase                5μl。KAPA T4 DNA Ligase 5 μl.
实施例1Example 1
一种基于高通量测序的线粒体基因组检测和分析方法,包括以下步骤:A method for mitochondrial genome detection and analysis based on high-throughput sequencing, comprising the following steps:
S1、PCR扩增线粒体全长DNAS1, PCR amplification of mitochondrial full-length DNA
按照常规方法从300μl全血中提取DNA,取2μl DNA样本在NanoDrop上进行浓度测定。测得DNA浓度要求OD260/OD280比值在1.8~2.0之间,OD260/OD230比值在1.8~2.2之间,以上两个比值可以判断所提取的DNA纯度如何。若超出上述范围,则可认为提取DNA纯度不符合要求,需重新提取或再纯化。根据测定的浓度,用DNA溶解缓冲液进一步稀释到浓度为50ng/μl。DNA was extracted from 300 μl of whole blood according to a conventional method, and 2 μl of the DNA sample was subjected to concentration determination on a NanoDrop. The measured DNA concentration requires an OD260/OD280 ratio between 1.8 and 2.0, and an OD260/OD230 ratio between 1.8 and 2.2. The above two ratios can determine the purity of the extracted DNA. If it is outside the above range, it can be considered that the purity of the extracted DNA does not meet the requirements and needs to be re-extracted or re-purified. Further diluted to a concentration of 50 ng/μl with DNA lysis buffer according to the measured concentration.
以稀释后的全血DNA为模板进行一步PCR扩增线粒体全长DNA,PCR反应体系如表1所示。 The mitochondrial full-length DNA was amplified by one-step PCR using the diluted whole blood DNA as a template. The PCR reaction system is shown in Table 1.
表1、PCR反应体系Table 1, PCR reaction system
Figure PCTCN2017082495-appb-000004
Figure PCTCN2017082495-appb-000004
本实施例中所用的引物对是发明人根据已公开的线粒体序列设计的,可以扩增线粒体全长DNA,具体序列如下:The primer pair used in this example was designed by the inventors according to the disclosed mitochondrial sequence, and the mitochondrial full-length DNA can be amplified, and the specific sequence is as follows:
Primer F(SEQ ID NO:1):ccgcacaagagtgctactctcctc,Primer F (SEQ ID NO: 1): ccgcacaagagtgctactctcctc,
Primer R(SEQ ID NO:2):gatattgatttcacggaggatggtg。Primer R (SEQ ID NO: 2): gatattgatttcacggaggatggtg.
上述PCR反应的程序如下:The procedure for the above PCR reaction is as follows:
Lid:105℃,Wait,Auto;Block:95℃,2min。Lid: 105 ° C, Wait, Auto; Block: 95 ° C, 2 min.
95℃,20sec;68℃,18min;30cycles。95 ° C, 20 sec; 68 ° C, 18 min; 30 cycles.
72℃,20min;4℃,hold。72 ° C, 20 min; 4 ° C, hold.
取2μl所得PCR产物和3μl染料混匀,用1%的琼脂糖凝胶进行电泳检测,电泳条件为100v,60min。结果如图1所示。第1泳道是分子大小标记,第2、3泳道是对不同样本进行线粒体扩增,大小约为16kb,第4泳道是阴性对照。2 μl of the obtained PCR product and 3 μl of the dye were mixed, and electrophoresis was carried out using a 1% agarose gel, and the electrophoresis conditions were 100 v for 60 min. The result is shown in Figure 1. Lane 1 is a molecular size marker, lanes 2 and 3 are mitochondrial amplification of different samples, approximately 16 kb in size, and lane 4 is a negative control.
S2、片段打碎S2, fragment broken
将扩增后的基因组DNA用Q800R超声波破碎仪打断。具体步骤如下:The amplified genomic DNA was disrupted with a Q800R sonicator. Specific steps are as follows:
往杯式探头杯中加入纯水,且没过钛合金探头。在0.5ml的离心管中转入40μl扩增产物,将其固定在样本固定器上,并轻轻弹走底部的气泡。将样本 固定器放入到杯式探头中,并再次往杯式探头中加入纯水,直至纯水液面与管中DNA液面平齐。Add pure water to the cup probe cup and have no titanium probe. Transfer 40 μl of the amplified product into a 0.5 ml centrifuge tube, attach it to the sample holder, and gently bounce off the bubbles at the bottom. Sample Place the holder into the cup probe and add pure water to the cup probe again until the level of pure water is flush with the DNA level in the tube.
提前开启Q800R的循环冷凝水系统,设置温度在3℃。在主机上设置好打断程序:Pulse on 20sec;Pulse off 30sec;Time 20min;Amplitude 40%。待温度降到设定温度3℃时,即可开启打断程序。程序运行完成后,将微管中的样本冷冻保存。所有样本完成打断后,关掉循环冷凝水系统,关闭发动机。Open the Q800R's circulating condensate system in advance and set the temperature at 3 °C. Set the interrupt program on the host: Pulse on 20sec; Pulse off 30sec; Time 20min; Amplitude 40%. When the temperature drops to the set temperature of 3 °C, the interrupting program can be turned on. After the program is run, the samples in the microtubes are stored frozen. After all samples have been interrupted, turn off the circulating condensate system and shut down the engine.
每例样本取1μl,用1.5%琼脂糖凝胶电泳检测,最终每例样本的片段长度应在500bp以下,峰值在350bp为合格。结果如图2所示。第1泳道是分子大小标记,第2、3泳道是为对不同样本进行DNA打断,片段大小在500bp以下,峰值约350bp左右。1 μl of each sample was taken and detected by 1.5% agarose gel electrophoresis. Finally, the fragment length of each sample should be below 500 bp, and the peak value at 350 bp was acceptable. The result is shown in Figure 2. The first lane is a molecular size marker, and the second and third lanes are DNA interrupts for different samples. The fragment size is below 500 bp and the peak is about 350 bp.
S3、末端修复S3, end repair
每例样本取50μl DNA片段,加入20μl末端修复反应液,总体积70μl。在热循环仪(扩增仪)上20℃孵育30min,结束后立即进行纯化。50 μl of DNA fragment was taken from each sample, and 20 μl of the end-repair reaction solution was added in a total volume of 70 μl. Incubate at 20 ° C for 30 min on a thermocycler (amplifier) and purify immediately after completion.
纯化的具体方法如下:向每例样本中加入120μl的AgencourtRAMPureRXP reagent,总体积190μl。用移液枪上下反复吸打,充分混匀溶液。室温孵育10分钟,使DNA与磁珠充分结合。将管放置于磁力架上,直至溶液变清澈,小心弃掉上清。将管继续留在磁力架上,加入200μl 80%酒精。室温孵育30秒以上,小心吸走酒精。将管继续留在磁力架上,加入200μl 80%酒精。室温孵育30秒以上,小心吸走酒精,此步应尽可能将酒精吸干净,但应注意不要吸走底部的磁珠。室温充分干燥。将管从磁力架上取出。The specific method of purification was as follows: 120 μl of Agencourt R AMPure R XP reagent was added to each sample in a total volume of 190 μl. Use a pipette to repeatedly pipe up and down and mix well. Incubate for 10 minutes at room temperature to allow the DNA to bind well to the magnetic beads. Place the tube on the magnetic stand until the solution becomes clear and carefully discard the supernatant. Leave the tube on the magnetic stand and add 200 μl of 80% alcohol. Incubate for 30 seconds at room temperature and carefully remove the alcohol. Leave the tube on the magnetic stand and add 200 μl of 80% alcohol. Incubate at room temperature for more than 30 seconds, carefully remove the alcohol. This step should be as clean as possible, but care should be taken not to remove the magnetic beads from the bottom. Dry at room temperature. Take the tube out of the magnetic stand.
S4、加AS4, plus A
向每个含有修复DNA-磁珠的管中加入50μl的加A反应混合物,总体积50μl。移液枪上下反复吸打,充分混匀样本。热循环仪(扩增仪)上30℃孵育30min,结束后立即进行纯化。 To each tube containing the repair DNA-magnetic beads, 50 μl of the A-addition reaction mixture was added in a total volume of 50 μl. The pipette is repeatedly sucked up and down, and the sample is thoroughly mixed. The thermocycler (amplifier) was incubated at 30 ° C for 30 min and purified immediately after completion.
纯化的具体方法如下:向每例样本中加入90μl的PEG/NaclSPRIRSolution,总体积140μl。用移液枪上下反复吸打,充分混匀溶液。室温孵育10分钟,使DNA与磁珠充分结合。将管放置于磁力架上,直至溶液变清澈,小心弃掉上清。将管继续留在磁力架上,加入200μl 80%酒精。室温孵育30秒以上,小心吸走酒精。将管继续留在磁力架上,加入200μl 80%酒精。室温孵育30秒以上,小心吸走酒精,此步应尽可能将酒精吸干净,但应注意不要吸走底部的磁珠。室温充分干燥。The specific method of purification was as follows: 90 μl of PEG/NaclSPRI R Solution was added to each sample in a total volume of 140 μl. Use a pipette to repeatedly pipe up and down and mix well. Incubate for 10 minutes at room temperature to allow the DNA to bind well to the magnetic beads. Place the tube on the magnetic stand until the solution becomes clear and carefully discard the supernatant. Leave the tube on the magnetic stand and add 200 μl of 80% alcohol. Incubate for 30 seconds at room temperature and carefully remove the alcohol. Leave the tube on the magnetic stand and add 200 μl of 80% alcohol. Incubate at room temperature for more than 30 seconds, carefully remove the alcohol. This step should be as clean as possible, but care should be taken not to remove the magnetic beads from the bottom. Dry at room temperature.
S5、加接头S5, add connector
向每个加了A的DNA样本管中加入以下反应液:Add the following reaction solution to each DNA sample tube to which A is added:
Figure PCTCN2017082495-appb-000005
Figure PCTCN2017082495-appb-000005
用移液枪上下反复吸打,充分混匀样本。热循环仪(扩增仪)上20℃孵育15min,结束后立即进行后续纯化步骤。纯化的具体方法如下:Use a pipette to repeatedly pipe up and down, and mix the sample thoroughly. The thermocycler (amplifier) was incubated at 20 ° C for 15 min, and the subsequent purification step was performed immediately after the end. The specific method of purification is as follows:
向每例样本中加入50μl的PEG/NaclSPRIRSolution总体积100μl。用移液枪上下反复吸打,充分混匀溶液。室温孵育10分钟,使DNA与磁珠充分结合。将管放置于磁力架上,直至溶液变清澈,小心弃掉上清。将管继续留在磁力架上,加入200μl 80%酒精。室温孵育30秒以上,小心吸走酒精。将管继续留在磁力架上,加入200μl 80%酒精。室温孵育30秒以上,小心吸走酒精,此步应尽可能将酒精吸干净,但应注意不要吸走底部的磁珠。室温充分干燥。将管从磁力架上取出。加入50μl的10mM Tris-HCl(pH 8.0),室温孵育2分钟,使得DNA从磁珠上分离开来。将上清全部转移至一个新的管中,继续后面的操作。50 μl of a total volume of 100 μl of PEG/Nacl SPRI R Solution was added to each sample. Use a pipette to repeatedly pipe up and down and mix well. Incubate for 10 minutes at room temperature to allow the DNA to bind well to the magnetic beads. Place the tube on the magnetic stand until the solution becomes clear and carefully discard the supernatant. Leave the tube on the magnetic stand and add 200 μl of 80% alcohol. Incubate for 30 seconds at room temperature and carefully remove the alcohol. Leave the tube on the magnetic stand and add 200 μl of 80% alcohol. Incubate at room temperature for more than 30 seconds, carefully remove the alcohol. This step should be as clean as possible, but care should be taken not to remove the magnetic beads from the bottom. Dry at room temperature. Take the tube out of the magnetic stand. 50 μl of 10 mM Tris-HCl (pH 8.0) was added and incubated for 2 minutes at room temperature to separate the DNA from the magnetic beads. Transfer all of the supernatant to a new tube and continue with the rest.
S6、前LM-PCR S6, pre-LM-PCR
前LM-PCR的反应体系和反应条件如表2和表3所示。The reaction system and reaction conditions of the pre-LM-PCR are shown in Tables 2 and 3.
表2、前LM-PCR的反应体系Table 2. Reaction system of pre-LM-PCR
试剂Reagent 用量Dosage
2×KAPA HiFiHotStartReadyMix2×KAPA HiFiHotStartReadyMix 25μl25μl
Pre-LM-PCR引物1&2,5μMPre-LM-PCR Primers 1&2, 5μM 5μl5μl
Adapter-ligated Sample Library(加接头的文库)Adapter-ligated Sample Library 20μl20μl
总体积total capacity 50μl50μl
表3、前LM-PCR的反应条件Table 3. Reaction conditions of pre-LM-PCR
Figure PCTCN2017082495-appb-000006
Figure PCTCN2017082495-appb-000006
样本在4℃或-20℃保存72小时,或者直接进行后续的纯化实验。前LM-PCR产物纯化的具体方法为:Samples were stored at 4 ° C or -20 ° C for 72 hours or directly subjected to subsequent purification experiments. The specific method for purification of the pre-LM-PCR product is:
每例样本中加入50μl的AgencourtRAMPureRXP reagent,总体积100μl。用移液枪上下反复吸打,充分混匀溶液。室温孵育10分钟,使DNA与磁珠充分结合。将管放置于磁力架上,直至溶液变清澈,小心弃掉上清。将管继续留在磁力架上,加入200μl 80%酒精。室温孵育30秒以上,小心吸走酒精。将管继续留在磁力架上,加入200μl 80%酒精。室温孵育30秒以上,小心吸走酒精,此步应尽可能将酒精吸干净,但应注意不要吸走底部的磁珠。室温充分干燥。将管从磁力架上取出。加入50μl 10mM Tris-HCl(pH 8.0),室温孵育2分钟,使得DNA从磁珠上分离开来。 50 μl of Agencourt R AMPure R XP reagent was added to each sample in a total volume of 100 μl. Use a pipette to repeatedly pipe up and down and mix well. Incubate for 10 minutes at room temperature to allow the DNA to bind well to the magnetic beads. Place the tube on the magnetic stand until the solution becomes clear and carefully discard the supernatant. Leave the tube on the magnetic stand and add 200 μl of 80% alcohol. Incubate for 30 seconds at room temperature and carefully remove the alcohol. Leave the tube on the magnetic stand and add 200 μl of 80% alcohol. Incubate at room temperature for more than 30 seconds, carefully remove the alcohol. This step should be as clean as possible, but care should be taken not to remove the magnetic beads from the bottom. Dry at room temperature. Take the tube out of the magnetic stand. 50 μl of 10 mM Tris-HCl (pH 8.0) was added and incubated for 2 minutes at room temperature to separate the DNA from the magnetic beads.
用1.5%凝胶电泳、Nanodrop及Qubit测定扩增后的DNA浓度及片段大小。如图3所示,第1泳道是分子大小标记,第2、3泳道是为对不同样本进行前LM-PCR,片段大小约在400bp左右。Qubit测定扩增后的第2、3泳道两个样品DNA浓度分别为34.2ng/μl和42.2ng/μl。The amplified DNA concentration and fragment size were determined by 1.5% gel electrophoresis, Nanodrop and Qubit. As shown in Fig. 3, the first lane is a molecular size marker, and the second and third lanes are for pre-LM-PCR of different samples, and the fragment size is about 400 bp. The DNA concentrations of the two samples in lanes 2 and 3 after amplification by Qubit assay were 34.2 ng/μl and 42.2 ng/μl, respectively.
S7、后PCRS7, post PCR
后PCR反应体系和反应条件如表4和表5所示。The post PCR reaction system and reaction conditions are shown in Tables 4 and 5.
表4、后PCR反应体系Table 4, post PCR reaction system
与磁珠结合的DNA(bead-bound captured DNA)DNA bound to magnetic beads (bead-bound captured DNA) 20μl20μl
KAPA HiFiHotStartReadyMixKAPA HiFiHotStartReadyMix 25μl25μl
Post-LM-PCR引物1&2(5μM)Post-LM-PCR Primer 1&2 (5μM) 5μl5μl
总体积total capacity 50μl50μl
表5、后PCR反应条件Table 5, post PCR reaction conditions
Figure PCTCN2017082495-appb-000007
Figure PCTCN2017082495-appb-000007
样本在4℃或-20℃保存72小时,或者直接进行后续的纯化实验。PCR后纯化的方法为:Samples were stored at 4 ° C or -20 ° C for 72 hours or directly subjected to subsequent purification experiments. The method of purification after PCR is:
将AgencourtRAMPureRXP reagent翻转几次,使得其充分混匀。往每个样本管中加入90μl的AgencourtRAMPureRXP reagent,涡旋2秒。室温放置15min。瞬时离心,然后将样本放入磁力架中,静置直至液体变得清澈。小 心吸走溶液,注意不要吸走底部的磁珠。不要从磁力板中移走样本管,直接往管中加入200μl 80%酒精,静置1min,然后吸出液体。重复该步骤一次。将管放入到加热器中,37±0.5℃,5min,或者直到管中酒精完全蒸发。用52μl的NF水溶解磁珠。移液器吹打10次,室温2min。将离心管放回到磁力板中直至溶液变清澈。每例样本直接转移50μl至1.5ml离心管中。Turn Agencourt R AMPure R XP reagent several times to mix thoroughly. 90 μl of Agencourt R AMPure R XP reagent was added to each sample tube and vortexed for 2 seconds. Leave at room temperature for 15 min. Centrifuge instantaneously, then place the sample in a magnetic stand and let stand until the liquid becomes clear. Carefully remove the solution, taking care not to remove the magnetic beads from the bottom. Do not remove the sample tube from the magnetic plate, add 200 μl of 80% alcohol directly to the tube, let stand for 1 min, and then aspirate the liquid. Repeat this step once. Place the tube in the heater at 37 ± 0.5 ° C for 5 min or until the alcohol in the tube has completely evaporated. The magnetic beads were dissolved with 52 μl of NF water. The pipette was blown 10 times at room temperature for 2 min. Place the tube back into the magnetic plate until the solution becomes clear. Each sample was directly transferred from 50 μl to a 1.5 ml centrifuge tube.
用1.5%凝胶电泳、Qubit及qPCR测定扩增后的DNA浓度及片段大小。经过多重PCR后,此时产物中将增加68bp附加物,应注意仔细观察峰值出现是否一致。凝胶电泳图如图4所示,第1泳道是分子大小标记,第2、3泳道是为对不同样本进行后PCR,峰值约在400bp左右。下表为Qubit及qPCR测定扩增后的DNA浓度如表6所示。The amplified DNA concentration and fragment size were determined by 1.5% gel electrophoresis, Qubit and qPCR. After multiplex PCR, a 68 bp addenda will be added to the product at this time. Care should be taken to see if the peaks appear consistent. The gel electrophoresis pattern is shown in Fig. 4. The first lane is a molecular size marker, and the second and third lanes are post-PCR for different samples, and the peak value is about 400 bp. The following table shows the DNA concentrations after amplification by Qubit and qPCR assays as shown in Table 6.
表6、Qubit及qPCR测定扩增后的DNA浓度Table 6. Qubit and qPCR for DNA concentration after amplification
样本编号Sample number 10311031 10371037
Qubit测定值(ng/μl)Qubit measurement value (ng/μl) 2.542.54 2.622.62
qPCR测定值(nM)qPCR measurement (nM) 12.212.2 9.89.8
对本发明构建的线粒体DNA文库进行高通量测序,进行生物信息分析得到检测样本线粒体基因组DNA序列,便可检测出不同突变类型和对之进行定量。由于高通量测序具有对常见和罕见变异高灵敏度,能发现线粒体的编码区外显子区绝大部分疾病相关变异。可以通过增加测序深度,提高突变检测的敏感度。在5000x的覆盖深度,获得更多的序列信息进行统计分析,可以达到的敏感度为0.1-1%。The high-throughput sequencing of the mitochondrial DNA library constructed by the present invention is carried out for bioinformatic analysis to obtain the mitochondrial genomic DNA sequence of the test sample, and different mutation types can be detected and quantified. Because high-throughput sequencing has high sensitivity to common and rare variants, most of the disease-related variants in the exon region of the coding region of mitochondria can be found. The sensitivity of mutation detection can be increased by increasing the depth of sequencing. At 5000x coverage depth, more sequence information is obtained for statistical analysis, and the sensitivity can be achieved from 0.1 to 1%.
以上所述实施例仅表达了本发明的几种实施方式,其描述较为具体和详细,但并不能因此而理解为对本发明专利范围的限制。应当指出的是,对于本领域的普通技术人员来说,在不脱离本发明构思的前提下,还可以做出若干变形和改进,这些都属于本发明的保护范围。因此,本发明专利的保护范围应以所附权利要求为准。 The above-mentioned embodiments are merely illustrative of several embodiments of the present invention, and the description thereof is more specific and detailed, but is not to be construed as limiting the scope of the invention. It should be noted that a number of variations and modifications may be made by those skilled in the art without departing from the spirit and scope of the invention. Therefore, the scope of the invention should be determined by the appended claims.

Claims (10)

  1. 一种基于高通量测序的线粒体基因组文库构建方法,其特征在于,包括以下步骤:A method for constructing a mitochondrial genomic library based on high-throughput sequencing, comprising the steps of:
    S1、自总DNA中一步PCR扩增线粒体全长DNA;S1, one-step PCR amplification of mitochondrial full-length DNA from total DNA;
    S2、将线粒体全长DNA打碎,得到DNA片段;S2, breaking the mitochondrial full-length DNA to obtain a DNA fragment;
    S3、对DNA片段进行末端修复,得到平末端DNA片段;S3, performing end repair on the DNA fragment to obtain a blunt-ended DNA fragment;
    S4、在平末端DNA片段3’端加A,得到加A的DNA片段;S4, adding A to the 3' end of the blunt-ended DNA fragment to obtain a DNA fragment with A added;
    S5、在加A的DNA片段的3’端加接头,得到加接头的DNA片段;S5, adding a linker at the 3' end of the DNA fragment added with A to obtain a DNA fragment to which a linker is added;
    S6、对加接头的DNA片段进行前LM-PCR;S6, performing pre-LM-PCR on the DNA fragment of the adaptor;
    S7、对LM-PCR产物进行后PCR。S7, post-PCR is performed on the LM-PCR product.
  2. 根据权利要求1所述的线粒体基因组文库构建方法,其特征在于,所述步骤S1具体为:提取全血DNA,并以其为模板PCR扩增线粒体全长DNA。The mitochondrial genomic library construction method according to claim 1, wherein the step S1 is specifically: extracting whole blood DNA, and using the template as a template to PCR-amplify mitochondrial full-length DNA.
  3. 根据权利要求2所述的线粒体基因组文库构建方法,其特征在于,步骤S1中所用引物对的具体序列为Primer F:ccgcacaagagtgctactctcctc,Primer R:gatattgatttcacggaggatggtg。The mitochondrial genomic library construction method according to claim 2, wherein the specific sequence of the primer pair used in the step S1 is Primer F: ccgcacaagagtgctactctcctc, and Primer R: gatattgatttcacggaggatggtg.
  4. 根据权利要求2所述的线粒体基因组文库构建方法,其特征在于,所述步骤S1中PCR反应体系如下:The method for constructing a mitochondrial genomic library according to claim 2, wherein the PCR reaction system in the step S1 is as follows:
    Figure PCTCN2017082495-appb-100001
    Figure PCTCN2017082495-appb-100001
  5. 根据权利要求4所述的线粒体基因组文库构建方法,其特征在于,所述步骤S1中PCR反应的程序如下:The method for constructing a mitochondrial genomic library according to claim 4, wherein the procedure of the PCR reaction in the step S1 is as follows:
    Lid:105℃,Wait,Auto;Block:95℃,2min;Lid: 105 ° C, Wait, Auto; Block: 95 ° C, 2 min;
    95℃,20sec;68℃,18min;30cycles;95 ° C, 20 sec; 68 ° C, 18 min; 30 cycles;
    72℃,20min;4℃,hold。72 ° C, 20 min; 4 ° C, hold.
  6. 根据权利要求1所述的线粒体基因组文库构建方法,其特征在于,步骤S6中前LM-PCR的反应体系如下:The method for constructing a mitochondrial genomic library according to claim 1, wherein the reaction system of the pre-LM-PCR in step S6 is as follows:
    Figure PCTCN2017082495-appb-100002
    Figure PCTCN2017082495-appb-100002
  7. 根据权利要求6所述的线粒体基因组文库构建方法,其特征在于,步骤S6中前LM-PCR的反应条件如下:98℃ 45sec;98℃ 15sec,60℃ 30sec,72℃ 30sec,9cycles;72℃ 1min;4℃。The method for constructing a mitochondrial genomic library according to claim 6, wherein the reaction conditions of the pre-LM-PCR in step S6 are as follows: 98 ° C 45 sec; 98 ° C 15 sec, 60 ° C 30 sec, 72 ° C 30 sec, 9 cycles; 72 ° C 1 min. ; 4 ° C.
  8. 根据权利要求1所述的线粒体基因组文库构建方法,其特征在于,步骤S7中后PCR反应的体系如下:The method for constructing a mitochondrial genomic library according to claim 1, wherein the system of the post PCR reaction in step S7 is as follows:
    Figure PCTCN2017082495-appb-100003
    Figure PCTCN2017082495-appb-100003
    后PCR反应的条件如下:98℃ 45sec;98℃ 15sec,60℃ 30sec,72℃ 30sec,14cycles;72℃ 1min;4℃。The conditions of the post-PCR reaction were as follows: 98 ° C 45 sec; 98 ° C 15 sec, 60 ° C 30 sec, 72 ° C 30 sec, 14 cycles; 72 ° C 1 min; 4 ° C.
  9. 根据权利要求1所述的线粒体基因组文库构建方法,其特征在于,所述步骤S3-S7包含纯化步骤。The mitochondrial genomic library construction method according to claim 1, wherein the steps S3-S7 comprise a purification step.
  10. 一种基于高通量测序的线粒体基因组文库,其特征在于,通过权利 要求1所述的线粒体基因组文库构建方法构建。 A mitochondrial genomic library based on high-throughput sequencing, characterized by The mitochondrial genomic library construction method described in claim 1 was constructed.
PCT/CN2017/082495 2016-05-10 2017-04-28 Mitochondrial genomic library based on high-throughput sequencing and method for constructing the library WO2017193832A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201610308792.8 2016-05-10
CN201610308792.8A CN105907748B (en) 2016-05-10 2016-05-10 A kind of mitochondrial genomes library and its construction method based on high-flux sequence

Publications (1)

Publication Number Publication Date
WO2017193832A1 true WO2017193832A1 (en) 2017-11-16

Family

ID=56749037

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2017/082495 WO2017193832A1 (en) 2016-05-10 2017-04-28 Mitochondrial genomic library based on high-throughput sequencing and method for constructing the library

Country Status (2)

Country Link
CN (1) CN105907748B (en)
WO (1) WO2017193832A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110607563A (en) * 2019-09-19 2019-12-24 北京市儿科研究所 Sequencing library of filter paper sheet dry blood spots and construction method thereof

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105925562A (en) * 2016-05-10 2016-09-07 广州嘉检医学检测有限公司 Method and kit for enriching 4000 human pathogenic target genes
CN105907748B (en) * 2016-05-10 2017-10-13 广州嘉检医学检测有限公司 A kind of mitochondrial genomes library and its construction method based on high-flux sequence
CN106520945A (en) * 2016-11-07 2017-03-22 江苏苏博生物医学股份有限公司 Next generation sequencing platform-based noninvasive target mitochondrion sequencing method
CN108220393B (en) * 2018-01-26 2019-01-08 广州海思医疗科技有限公司 A kind of high-throughput quickly method of detection mitochondrial gene mutation or missing
CN108949942B (en) * 2018-07-17 2020-08-11 浙江大学 Mitochondrial whole genome sequencing method based on high-throughput sequencing
CN111172157B (en) * 2020-01-22 2021-11-09 福州福瑞医学检验实验室有限公司 Construction method of human single cell mitochondria high-throughput sequencing library and kit for library construction
CN111304196A (en) * 2020-03-06 2020-06-19 佛山科学技术学院 Buffalo animal mitochondrial genome capture probe kit
CN111172159A (en) * 2020-03-06 2020-05-19 佛山科学技术学院 Bovine mitochondrial genome capture probe kit
CN112908411B (en) * 2021-01-12 2024-05-14 广州市金域转化医学研究院有限公司 Mitochondrial variation site database and establishment method and application thereof
CN114015749A (en) * 2021-10-18 2022-02-08 浙江博圣生物技术股份有限公司 Construction method of mitochondrial genome sequencing library based on high-throughput sequencing and amplification primer

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103103624A (en) * 2011-11-15 2013-05-15 深圳华大基因科技有限公司 Method for establishing high-throughput sequencing library and application thereof
CN103173441A (en) * 2013-02-05 2013-06-26 深圳华大基因研究院 Amplification method, primer, sequencing method and mutation detection method of mitochondria whole genome DNA (Deoxyribonucleic Acid)
CN103571854A (en) * 2012-07-18 2014-02-12 深圳华大基因科技有限公司 SUCLA2 gene mutant and its application
CN103602735A (en) * 2013-11-06 2014-02-26 复旦大学 Method for precisely determining high-frequency and low-frequency mutations of mitochondrial DNA (deoxyribonucleic acid) by high-throughput sequencing
CN103614482A (en) * 2013-12-09 2014-03-05 广州赛哲生物科技有限公司 Method for carrying out non-invasive measurement on mitochondrial DNA (deoxyribonucleic acid) based on high-flux gene sequencing
CN104099349A (en) * 2013-04-08 2014-10-15 深圳华大基因科技有限公司 Maple syrup urine disease related gene mutation, and detection method and purpose thereof
CN105087767A (en) * 2014-09-19 2015-11-25 深圳华大基因科技有限公司 Method for detecting mitochondrial genomes and primer
CN105112499A (en) * 2015-06-16 2015-12-02 广州燃石医学检验所有限公司 Method for enriching target regions of 168 genes based on multi-probes
CN105907748A (en) * 2016-05-10 2016-08-31 广州嘉检医学检测有限公司 Mitochondrial genome library based on high-throughput sequencing and building method thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102392037A (en) * 2011-12-12 2012-03-28 江南大学 Cloning and expression of beta-1, 4-endo-mannanase (An Man5A) gene

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103103624A (en) * 2011-11-15 2013-05-15 深圳华大基因科技有限公司 Method for establishing high-throughput sequencing library and application thereof
CN103571854A (en) * 2012-07-18 2014-02-12 深圳华大基因科技有限公司 SUCLA2 gene mutant and its application
CN103173441A (en) * 2013-02-05 2013-06-26 深圳华大基因研究院 Amplification method, primer, sequencing method and mutation detection method of mitochondria whole genome DNA (Deoxyribonucleic Acid)
CN104099349A (en) * 2013-04-08 2014-10-15 深圳华大基因科技有限公司 Maple syrup urine disease related gene mutation, and detection method and purpose thereof
CN103602735A (en) * 2013-11-06 2014-02-26 复旦大学 Method for precisely determining high-frequency and low-frequency mutations of mitochondrial DNA (deoxyribonucleic acid) by high-throughput sequencing
CN103614482A (en) * 2013-12-09 2014-03-05 广州赛哲生物科技有限公司 Method for carrying out non-invasive measurement on mitochondrial DNA (deoxyribonucleic acid) based on high-flux gene sequencing
CN105087767A (en) * 2014-09-19 2015-11-25 深圳华大基因科技有限公司 Method for detecting mitochondrial genomes and primer
CN105112499A (en) * 2015-06-16 2015-12-02 广州燃石医学检验所有限公司 Method for enriching target regions of 168 genes based on multi-probes
CN105907748A (en) * 2016-05-10 2016-08-31 广州嘉检医学检测有限公司 Mitochondrial genome library based on high-throughput sequencing and building method thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
LIM, K.S. ET AL.: "Quantitative Mitochondrial DNA Mutation Analysis by Denaturing HPLC", CLINICAL CHEMISTRY, vol. 53, no. 6, 31 December 2007 (2007-12-31), pages 1046 - 1052, XP055439704 *
LIU, LI ET AL.: "Analysis of the frequency and hot spot of mitochondrial DNA oxidative damage by ligation mediated PCR", CHINESE JOURNAL OF INDUSTRIAL HYGIENE AND OCCUPATIONAL DISEASES, vol. 18, no. 3, 30 June 2000 (2000-06-30), pages 151 - 154 *
LIU, LI ET AL.: "The application of ligation mediated PCR on mitochondrial DNA sequencing", CHINA OCCUPATIONAL MEDICINE, vol. 27, no. 3, 30 June 2000 (2000-06-30), pages 16 - 18 *
O' MALLEY, R.C. ET AL.: "An adapter ligation-mediated PCR method for high-throughput mapping of T-DNA inserts in the Arabidopsis genome", NATURE PROTOCOLS, vol. 2, no. 11, 8 November 2007 (2007-11-08), pages 2910 - 2917, XP055249949 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110607563A (en) * 2019-09-19 2019-12-24 北京市儿科研究所 Sequencing library of filter paper sheet dry blood spots and construction method thereof

Also Published As

Publication number Publication date
CN105907748B (en) 2017-10-13
CN105907748A (en) 2016-08-31

Similar Documents

Publication Publication Date Title
WO2017193832A1 (en) Mitochondrial genomic library based on high-throughput sequencing and method for constructing the library
AU2015296029B2 (en) Tagging nucleic acids for sequence assembly
CN107177670B (en) Method for detecting Parkinson disease pathogenic gene mutation in high throughput manner
ES2573277T3 (en) Methods, compositions and kits for the generation of samples depleted in rRNA or for the isolation of rRNA from samples
US10941448B1 (en) Methods for assessing risk of developing a viral disease using a genetic test
WO2017193833A1 (en) Method and kit comprising 4,000 human pathogenic target genes
WO2020135259A1 (en) Sequencing library construction kit and use method and application thereof
JP6321757B2 (en) Primer set for NGS library preparation, NGS library preparation method and kit using the same
CN108486234A (en) A kind of method and its application of CRISPR partings PCR
WO2018149091A1 (en) Method for constructing circular rna high-throughput sequencing library and kit thereof
WO2018113351A1 (en) Method for detecting dna genetic marker
CN110886021B (en) Construction method of single-cell DNA library
WO2013056640A1 (en) A method for preparing a nucleic acid library, its uses and kits
JP2021525515A (en) Compositions, methods and systems for processing or analyzing multiple nucleic acid samples
WO2012037878A1 (en) Nucleic acid index and application thereof
CN109852689B (en) Group of vascular malformation related biomarkers and related detection kit
CN109097461B (en) Detection reagent for cardiomyopathy related genes and application thereof
WO2018184495A1 (en) Method for constructing amplicon library through one-step process
WO2021114713A1 (en) Cell lysis solution, kit, and application
WO2019006975A1 (en) In situ whole genome chromatin conformation capture method for infinitesimal cells
WO2021127406A1 (en) Methods of producing target capture nucleic acids
KR20220077907A (en) Library building method and application
CN106754903A (en) The primer pair and method of a kind of whole genome amplification for human mitochondrial
WO2019052322A1 (en) Method for analyzing oligonucleotide sequence impurity based on high throughput sequencing and use
WO2021219114A1 (en) Sequencing method, analysis method therefor and analysis system thereof, computer-readable storage medium, and electronic device

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17795450

Country of ref document: EP

Kind code of ref document: A1

122 Ep: pct application non-entry in european phase

Ref document number: 17795450

Country of ref document: EP

Kind code of ref document: A1